Skip to content
Open access

Cobalt(II) and zinc(II) complexes with 2-propionate-based non-steroidal anti-inflammatory drugs.

Jul 2026 · Dalton Transactions · Vol 55, pp. 11380-11393 · 0 citations
Medicine

TL;DR

Three cobalt(II) and three zinc(II) complexes with the non-steroidal anti-inflammatory drugs fenoprofen, loxoprofen and flurbiprofen as ligands were synthesized and characterized with diverse techniques including single-crystal X-ray crystallography to reveal reversible binding to both albumins.

Abstract

Three cobalt(II) and three zinc(II) complexes with the non-steroidal anti-inflammatory drugs fenoprofen, loxoprofen and flurbiprofen as ligands were synthesized and characterized with diverse techniques including single-crystal X-ray crystallography. The in vitro scavenging activity of the complexes against 1,1-diphenyl-picrylhydrazyl and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) free radicals and the ability to reduce H2O2 were studied in the context of the antioxidant activity studies. The complexes have shown significant activity towards H2O2. Antimicrobial testing against four bacteria revealed that the complexes were more active than free drugs. The complexes may interact with calf-thymus DNA via intercalation as revealed from the techniques employed. The affinity of the complexes for bovine and human serum albumins was evaluated by fluorescence emission spectroscopy and the corresponding binding constants revealed reversible binding to both albumins.

Read PDF

Similar papers

Open access Sep 2026

Ni(II) Complexes of 2-Imine-8-Hydroxyquinolines: Characterization, Albumin Binding and Cytotoxicity

Nickel(II) offers an appealing base for metallodrug design as it is abundant, inexpensive and forms well-defined complexes with N,O-donor ligands. Therefore, five Ni(II) complexes containing two tridentate 2-imine-8-hydroxyquinoline Schiff base ligands, derived from morpholine, piperidine, imidazole or 2-methyl-1H-limi...

Sofia Marcão, Leonor Côrte-Real, Alice Alborghetti et al. · 0 citations
Open access Aug 2026

Bioactive Azamacrocyclic Zinc(II) Complexes: Synthesis and Characterisation

Reduction of Me8[14]diene·2HClO4 (L·2HClO4) afforded three isomeric ligands (LA, LB and LC), among which LC underwent cyanoethylation with excess acrylonitrile to form the bis-cyanoethyl derivative (LCX). Reaction of LCX with zinc(II) chloride yielded the six-coordinate complex [Zn(LCX)Cl2], which subsequently underwen...

Tumpa Rani Majumder, Pradip Paul, S. Rabi et al. · 0 citations
Open access 2026

SYNTHESIS, CHARACTERIZATION, ANTIOXIDANTANDANTICANCER STUDIES OF COPPER(II) COMPLEXESOF2-AMINOBENZIMIDAZOLE SCAFFOLD SCHIFFBASES

In vitro anticancer activities of the Schiff bases (L1–L4) and their Cu(II) complexes were assessed against HeLa cancer cell lines using the MTT assay, and a hydroxyl-substituted ligand and its Cu(II) complex demonstrated marked cytotoxic activity towards the HeLa cell lines.

A. Krishnaveni, M. Kalanithi, M. Karthikeyan et al. · 0 citations
Open access Aug 2026

Zn (II) Metal Complexes with Schiff-Bases (Ligand) Synthesis, Characterization and its Biological activity

In this study, metal ions of Zn (II) and Schiff-base ligand have been synthesised using a 2:1 molar ratio (2L:M). To confirm the metal (II) complexes were effectively synthesised, the compound was characterized through PNMR, EDX, Elemental analysis, FTIR, LCMS, magnetic susceptibility measurement, and UV-Vis. The obtai...

Singh Devendra Kumar, Saxena Bipin Bahadur, Singh Vipin Kumar · 0 citations
Open access

BENZIMIDAZOLE-DERIVED METAL COMPLEXES: STRUCTURAL INSIGHTS AND ANTIMICROBIAL POTENTIAL AGAINST STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI

The stable metal complexes of transition metals with benzimidazole derivatives lead to improved physicochemical and biological properties of these compounds. The development of antimicrobial agents becomes possible through complex design based on benzimidazole-derived compounds. The research focused on creating and ana...

S. Alasalli, F. T. Saeed, H. Y. Hussien · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.